NCT06948955 2026-03-09Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal TumorsCogent Biosciences, Inc.Available
NCT00094029 2012-03-09A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248PfizerApproved for marketing